Adagene Inc. (ADAG) stock
ADAGNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.48−0.12 (-7.50%)
Close on Nov 17, 2026Market cap $87.66MP/E –Yield –
Adagene total assets
Total assets on the balance sheet at the end of each period.
Adagene's total assets was $133.58M at Jun 30, 2026. For fiscal 2025 it was $78.26M, down 12.3% from the year before. The highest annual figure on record is $189.51M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $78.26M | -12.3% |
| FY2024 | Dec 31, 2024 | $89.27M | -22.9% |
| FY2023 | Dec 31, 2023 | $115.73M | -24.1% |
| FY2022 | Dec 31, 2022 | $152.40M | -19.6% |
| FY2021 | Dec 31, 2021 | $189.51M | +124.9% |
| FY2020 | Dec 31, 2020 | $84.26M | -20.4% |
| FY2019 | Dec 31, 2019 | $105.89M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $133.58M | +32.5% |
| Q4 FY2025 | Dec 31, 2025 | $78.26M | -32.4% |
| Q2 FY2025 | Jun 30, 2025 | $66.52M | -56.4% |
| Q4 FY2024 | Dec 31, 2024 | $89.27M | -52.9% |
| Q2 FY2024 | Jun 30, 2024 | $100.78M | +19.6% |
| Q4 FY2023 | Dec 31, 2023 | $115.73M | +9.3% |
| Q4 FY2022 | Dec 31, 2022 | $152.40M | – |
| Q4 FY2021 | Dec 31, 2021 | $189.51M | – |
| Q4 FY2020 | Dec 31, 2020 | $84.26M | – |
| Q4 FY2019 | Dec 31, 2019 | $105.89M | – |
See a number that looks wrong?